TY - BOOK
T1 - Supraspinal transient receptor potential subfamily V Member 1 (TRPV1) in pain and psychiatric disorders
AU - Madasu, Manish K.
AU - Roche, Michelle
AU - Finn, David P.
N1 - Publisher Copyright:
© 2015 S. Karger AG, Basel.
PY - 2015
Y1 - 2015
N2 - The transient receptor potential subfamily V member 1 (TRPV1) belongs to the diverse transient receptor potential (TRP) family of cation channels. It was first characterized in primary afferent fibres as a receptor for capsaicin. Peripheral TRPV1 has a very well-described role in nociception. However, TRPV1 is now recognized to have a broader distribution and function, with supraspinal/brain TRPV1 known to modulate pain processing. Recently, studies employing histological, genetic and pharmacological approaches have provided evidence that supraspinal TRPV1 also modulates brain neurobiology and behaviours related to anxiety, depression and schizophrenia. Key brain regions involved in TRPV1-mediated modulation of pain and affect include the periaqueductal grey, hippocampus and medial prefrontal cortex. Thus, TRPV1 in the brain is emerging as an important molecular substrate which is dually implicated in both pain and psychiatric disorders, and represents a novel therapeutic target for these conditions and their comorbidity.
AB - The transient receptor potential subfamily V member 1 (TRPV1) belongs to the diverse transient receptor potential (TRP) family of cation channels. It was first characterized in primary afferent fibres as a receptor for capsaicin. Peripheral TRPV1 has a very well-described role in nociception. However, TRPV1 is now recognized to have a broader distribution and function, with supraspinal/brain TRPV1 known to modulate pain processing. Recently, studies employing histological, genetic and pharmacological approaches have provided evidence that supraspinal TRPV1 also modulates brain neurobiology and behaviours related to anxiety, depression and schizophrenia. Key brain regions involved in TRPV1-mediated modulation of pain and affect include the periaqueductal grey, hippocampus and medial prefrontal cortex. Thus, TRPV1 in the brain is emerging as an important molecular substrate which is dually implicated in both pain and psychiatric disorders, and represents a novel therapeutic target for these conditions and their comorbidity.
UR - http://hdl.handle.net/10379/15075
UR - https://www.scopus.com/pages/publications/84945183707
U2 - 10.13025/22467
DO - 10.13025/22467
M3 - Edited Book
VL - 30
T3 - Modern Trends in Pharmacopsychiatry
BT - Supraspinal transient receptor potential subfamily V Member 1 (TRPV1) in pain and psychiatric disorders
PB - KARGER
ER -